Immediate U.S. launch planned for Farxiga®-equivalent diabetes drug; opportunity pegged at $10.2 billion in annual market size
Immediate U.S. launch planned for dapagliflozin-metformin ER tablets; addressable market estimated at $514 millionannually
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals
Searches for diabetes, heart conditions, and metabolism-related risks are rising sharply, with Tier 2 cities outpacing metros in specialist consultations
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
Subscribe To Our Newsletter & Stay Updated
